A new antibiotic compound,gephyronic acid was isolated from the culture broth of the myxobacterium, Archangium gephyra strain Ar 3895. Up to 3mg/liter was produced during the logarithmic and stationary growth phase. The compoundis an aliphatic acid, which tends to form a hemiacetal. Both forms inhibited growth of yeasts and molds (MIC l~25/zg/ml) and had a cytostatic effect on mammalian cell cultures (IC50 10~60ng/ml). Gephyronic acid is a specific inhibitor of eukaryotic protein sythesis showing an IC50 of 1~2x 10~7mol/liter in an in vitro translation assay.
A new antibiotic compound,gephyronic acid was isolated from the culture broth of the myxobacterium, Archangium gephyra strain Ar 3895. Up to 3mg/liter was produced during the logarithmic and stationary growth phase. The compoundis an aliphatic acid, which tends to form a hemiacetal. Both forms inhibited growth of yeasts and molds (MIC l~25/zg/ml) and had a cytostatic effect on mammalian cell cultures (IC50 10~60ng/ml). Gephyronic acid is a specific inhibitor of eukaryotic protein sythesis showing an IC50 of 1~2x 10~7mol/liter in an in vitro translation assay.
During our screening program for antibiotics from myxobacteria, culture supernatants of different strains of Archangiumgephyra showed antibiotic activity against yeasts and molds. The activity of strain Ar 3895 was further investigated and could be identified as a new, highly substituted aliphatic acid with a keto group. The compoundshowed a tendency to form an intramolecular hemiacetal ( Fig. 1) . It was named gephyronic acid. In this paper we describe the production, isolation, and the physico-chemical and biological properties of gephyronic acid. The structure elucidation will be published elsewhere1}.
Microorganism and Culture Conditions The producing organism was Archangium gephyra strain Ar 3895 isolated in 1988 at the GBFfrom a soil sample collected on the island of Mallorca, Spain. It was grown in M7 liquid medium containing 0.5% Probion (single cell protein from Hoechst A.G.), 0.5% starch, 0.2% glucose, 0.1% yeast extract, 0.1% MgSO4 à" 7H2O, 0.1% CaCl2 -2H2O, O.l mg/liter cyanocobalamin, 1% HEPES, pH 7.4. Batch cultures of 100 or 500ml in 250-ml or 1,000-ml Erlenmeyer flasks, respectively, were incubated at 30°C on a gyratory shaker at 160rpm for 3~7days.
Production Gephyronic acid production on a larger scale was performed in M7 liquid medium. For example, a 500-ml culture grown for 3days on a gyratory shaker was inoculated into 10liter in a 15-liter fermentor with a flat-blade turbine stirrer. After 3 days the content of the first fermentor was inoculated into a second one with 300liter of medium to which 1% (v/v) of an absorber resin, e.g., Amberlite XAD-16 (Rohm & Haas, in a 365-liter draft tube bioreactor (Giovanola Freres SA, Monthey, Switzerland). The pH rose during the fermentation and was kept at 7.7 by titration with 5% H2SO4. Antibiotic production was followed by HPLC analysis (see below). Gephyronic acid was produced during the logarithmic and early stationary phase and reached a concentration of 3 mg/liter after 4days. The cell density was 6 x 108/ml at that time. At harvest, the absorber resin was separated from the culture broth by passage through a process filter of 210/im pore size. (hemiacetal) . After spraying the plates with vanillin/ sulfuric acid reagent and heating to 120°C, both forms of gephyronic acid gave purple spots. 13C NMRand high resolution FAB-MS gave a molecular formula of C26H48O8. Detailed data will be published with the structure elucidation1*. The optical rotation of gephyronic acid (keto form) was [a]£°+4.6.5°(c 1.0, MeOH). The UVspectrum of gephyronic acid in methanol only shows end absorption.
The IR spectrum (Fig. 3) was measured with a Nicolet 20 DXBFT-IR spectrometer. Biological Activity As shown in Table 1 , gephyronic acid (keto form) had 23 no effect on bacteria, but was active against all yeasts and most filamentous fungi tested. The MIC values for yeasts were generally lower than those for molds.
Gephyronic acid also showed a cytostatic effect in mammalian cell cultures ( Table 2 ). The IC50 values varied from 10 to 60ng/ml. The hemiacetal was also tested against different fungi and the mouse cell line L929, but there was no significant difference between both forms of gephyronic acid concerning their biological activities in these assays. The organisms were grown in standard media (bacteria: peptone 1%, meat extract 0.1%, yeast extract 0.1%, pH 7.0; fungi: malt extract 3%, peptone 0.3%, pH 5.6).
Determined by the agar diffusion test using paper discs of 6mmdiameter with 20fig gephyronic acid. and 10% CO2. Growth of the yeast and of the human cells stopped immediately, when gephyronic acid was added to the culture medium. But in both cases, the effect was reversible. The cells started to grow soon after the culture mediumwas exchanged against fresh medium without antibiotic and reached the same cell density as the control, i.e., gephyronic acid had a cytostatic effect on eukaroytic cells.
At gephyronic acid concentrations around the IC50 value, the cells of the fibroblast-like mouse cell line L929 (ATCC CCL 1) growing in DME (high glucose) medium+10%newborn calf serum became elongated and partly sickle-shaped, and formed a monolayer with the cells partly aligned in parallel. By screening for this characteristic morphological effect, we found that gephyronic acid was apparently present in 19 of the 55 Archangiumstrains tested. Whenpositive extracts were analyzed by HPLC, the antibiotic indeed was found in each case. But so far it has not been detected in any other genus of myxobacteria. In order to examine the modeof action of gephyronic acid, feeding experiments with radioactive precursors of the main biomacromolecules were done. Fig. 6 shows the incorporation of leucine, uridine, and thymidine by the human leukemic cell line K-562 into TCAinsoluble material with and without gephyronic acid. While incorporation of leucine was drastically reduced in the presence of the antibiotic, uridine incorporation was only gradually reduced, and that of thymidine was hardly influenced. These findings suggested that protein synthesis is the primary target of gephyronic acid.
Feeding experiments with yeasts supported this assumption.
Therefore the effect of gephyronic acid was examined in two in vitro translation systems: in a rabbit reticulocytes lysate (Fig. 7) and in wheat germ extract (both from Boehringer, Mannheim). Leucine or methionine incorporation into the translation product of TMVRNA(Boehringer, Mannheim) was measured in the presence of different concentrations of gephyronic acid and cycloheximide, a knowninhibitor of eukaryotic The IC50 values for gephyronic acid derived from the inhibition curves were 1.4 x 10~7 m with the reticulocytes lysate (leucine incorporation) and 1.7 x 10~7 mwith the wheat germ extract (methionine incorporation). Nearly identical values were found for cycloheximide.
Discussion
Gephyronic acid is the first antibiotic published from an Archangium species. Our screening results suggest that it is widely distributed in this genus, but seems to be restricted to it. Thus, it could be used as a taxonomic marker. Gephyronic acid also is the first antbiotic reported from myxobacteria that specifically inhibits eukaryotic protein synthesis. Inhibitors of the prokaryotic translation system have been reported from different genera of myxobacteria, viz., angiolam2) from Angiococcus disciformis, althiomycin3) from Cystobacterfuscus and myxovalargin4) and althiomycin3) from Myxococcus strains.
